The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA
LAM
1 other identifier
observational
10
1 country
1
Brief Summary
Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 22, 2025
CompletedFirst Submitted
Initial submission to the registry
October 24, 2025
CompletedFirst Posted
Study publicly available on registry
October 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
November 4, 2025
October 1, 2025
1.2 years
October 24, 2025
October 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Area of sensory change after nerve block
20 min after nerve block placement
Eligibility Criteria
Patients 18 years or older who are undergoing skin grafting surgeries
You may qualify if:
- years or older
- Scheduled surgery for STSG w/ donor site coming from thigh
- Care team requests LAM nerve block
- Anticipated postop pain in the cutaneous areas of anterior and lateral thigh
You may not qualify if:
- Inability to communicate sensation or motor changes in their body
- Preexisting sensory or motor deficits in the femoral nerve distribution
- Contraindication to the medication used or a peripheral nerve block, such as allergy to amide local anesthetics, severe liver dysfunction, injection site infection etc
- Pregnancy
- Prisoners
- Non-English Speaking/reading
- Surgeries with anticipated or actual duration of 6 hours or longer
- TBSA 20% or greater
- Severe distracting injuries/polytrauma (e.g., large or significant bone fractures)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Harborview Medical Center
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorothy Wang, MD, MHA
University of Washington
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Acting Assistant Professor, Department of Anesthesiology and Pain Medicine
Study Record Dates
First Submitted
October 24, 2025
First Posted
October 28, 2025
Study Start
October 22, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
November 4, 2025
Record last verified: 2025-10